Toosendanin inhibits osteoclast formation and alleviate postmenopausal osteoporosis by regulating the p38 signaling pathway

作者：Tingting Tan, Tao Li, Cheng Xiang, Zhengxiao Ouyang · 发表于：International Immunopharmacology · 年份：2023 · DOI：10.1016/j.intimp.2023.109745 · 被引用次数：15 · 研究领域：Bone Metabolism and Diseases、Bone health and treatments、Inflammatory mediators and NSAID effects